Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one-Reference-Cited by-同舟云学术

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one

Published:2010-05 Issue:10 Volume:20 Page:3182-3185
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Velaparthi Upender,Saulnier Mark G.,Wittman Mark D.,Liu Peiying,Frennesson David B.,Zimmermann Kurt,Carboni Joan M.,Gottardis Marco,Li Aixin,Greer Ann,Clarke Wendy,Yang Zheng,Menard Krista,Lee Francis Y.,Trainor George,Vyas Dolatrai

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. The insulin-like growth factor-I receptor as a target for cancer therapy

2. Insulin-like growth factors and neoplasia

3. The IGF-1 receptor in cancer biology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzimidazole: A Multifacted Nucelus for Anticancer Agents;Current Organic Chemistry;2021-03-26

2. Recent Progress of Benzimidazole Hybrids for Anticancer Potential;Current Medicinal Chemistry;2020-10-28

3. Synthesizing Chiral Drug Intermediates by Biocatalysis;Applied Biochemistry and Biotechnology;2020-04-22

4. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates;Bioorganic & Medicinal Chemistry;2018-04

5. Efficient one-pot synthesis of enantiomerically pure N-protected-α-substituted piperazines from readily available α-amino acids;New Journal of Chemistry;2018